{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:28:59Z","timestamp":1773156539785,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Initial differential diagnosis and prognosis for patients admitted to intensive care with suspected sepsis remain arduous. Hepcidin has emerged as a potential biomarker for sepsis. Here we report data on the relevance of levels of hepcidin versus other biomarkers as a diagnostic and prognostic tool for sepsis. 164 adult patients admitted to the intensive care unit (ICU) within 24\u00a0h upon arrival to the hospital were included. Blood samples collected daily for seven consecutive days and hepcidin levels, heparin binding protein (HBP) levels and standard biomarkers were determined. Blood cultures were initiated at inclusion. Clinical scores were evaluated daily and mortality after 28- and 180-days was recorded. One hundred of the patients were found to fulfil the criteria for sepsis whereas 64 did not. Hepcidin levels at admission were significantly higher in the septic than in the non-septic patients. In septic patients hepcidin levels declined significantly already at 24\u00a0h followed by a steady decline. A significant negative correlation was observed between hepcidin levels and SAPS 3 in patients with sepsis. Hepcidin levels at inclusion were significantly higher among septic patients that survived 180-days and predicted mortality. Our data show that hepcidin levels are indicative of sepsis in patients admitted to the ICU and has a prognostic value for mortality.<\/jats:p>","DOI":"10.1038\/s41598-022-18826-0","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T11:05:49Z","timestamp":1662030349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hepcidin discriminates sepsis from other critical illness at admission to intensive care"],"prefix":"10.1038","volume":"12","author":[{"given":"Jon","family":"Olinder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"B\u00f6rjesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Norrman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joakim","family":"Carlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Annborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Herwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"issue":"8","key":"18826_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 801\u2013810 (2016).","journal-title":"JAMA"},{"issue":"12","key":"18826_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1097\/CCM.0000000000003342","volume":"46","author":"CJ Paoli","year":"2018","unstructured":"Paoli, C. J., Reynolds, M. A., Sinha, M., Gitlin, M. & Crouser, E. Epidemiology and costs of sepsis in the United States\u2014an analysis based on timing of diagnosis and severity level. Crit. Care Med. 46(12), 1889\u20131897 (2018).","journal-title":"Crit. Care Med."},{"issue":"21","key":"18826_CR3","first-page":"2063","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus, D. C. & van der Poll, T. Severe sepsis and septic shock. N. Engl. J. Med. 369(21), 2063 (2013).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"18826_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1631\/jzus.2005.B1045","volume":"6","author":"E Gruys","year":"2005","unstructured":"Gruys, E., Toussaint, M. J., Niewold, T. A. & Koopmans, S. J. Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. B 6(11), 1045\u20131056 (2005).","journal-title":"J. Zhejiang Univ. Sci. B"},{"issue":"3","key":"18826_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes, A. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit. Care Med. 45(3), 486\u2013552 (2017).","journal-title":"Crit. Care Med."},{"issue":"10219","key":"18826_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: Analysis for the Global Burden of Disease Study. Lancet 395(10219), 200\u2013211 (2020).","journal-title":"Lancet"},{"issue":"4","key":"18826_CR7","doi-asserted-by":"publisher","first-page":"ofw207","DOI":"10.1093\/ofid\/ofw207","volume":"3","author":"L Mellhammar","year":"2016","unstructured":"Mellhammar, L. et al. Sepsis incidence: A population-based study. Open Forum Infect Dis. 3(4), ofw207. https:\/\/doi.org\/10.1093\/ofid\/ofw207 (2016).","journal-title":"Open Forum Infect Dis."},{"issue":"7","key":"18826_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/aas.13587","volume":"64","author":"G Strandberg","year":"2020","unstructured":"Strandberg, G., Walther, S., Ohman, C. A. & Lipcsey, M. Mortality after severe sepsis and septic shock in swedish intensive care units 2008\u20132016\u2014a nationwide observational study. Acta Anaesthesiol. Scand. 64(7), 967\u2013975 (2020).","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"1","key":"18826_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccc.2017.08.010","volume":"34","author":"TSR van Engelen","year":"2018","unstructured":"van Engelen, T. S. R., Wiersinga, W. J., Scicluna, B. P. & van der Poll, T. Biomarkers in sepsis. Crit. Care Clin. 34(1), 139\u2013152 (2018).","journal-title":"Crit. Care Clin."},{"issue":"1","key":"18826_CR10","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/cc8872","volume":"14","author":"C Pierrakos","year":"2010","unstructured":"Pierrakos, C. & Vincent, J. L. Sepsis biomarkers: A review. Crit Care. 14(1), R15 (2010).","journal-title":"Crit Care."},{"key":"18826_CR11","volume":"344","author":"R Laxminarayan","year":"2012","unstructured":"Laxminarayan, R. & Heymann, D. L. Challenges of drug resistance in the developing world. BMJ (Clin. Res. Ed.) 344, e1567 (2012).","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"6","key":"18826_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/joim.12604","volume":"281","author":"J Fisher","year":"2017","unstructured":"Fisher, J. & Linder, A. Heparin-binding protein: A key player in the pathophysiology of organ dysfunction in sepsis. J. Intern. Med. 281(6), 562\u2013574 (2017).","journal-title":"J. Intern. Med."},{"issue":"Suppl 1","key":"18826_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.bjm.2018.05.007","volume":"49","author":"M Kandil","year":"2018","unstructured":"Kandil, M., Khalil, G., El-Attar, E., Shehata, G. & Hassan, S. Accuracy of heparin binding protein: As a new marker in prediction of acute bacterial meningitis. Braz. J. Microbiol. 49(Suppl 1), 213\u2013219 (2018).","journal-title":"Braz. J. Microbiol."},{"issue":"1","key":"18826_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1128\/iai.45.1.29-35.1984","volume":"45","author":"WM Shafer","year":"1984","unstructured":"Shafer, W. M., Martin, L. E. & Spitznagel, J. K. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect. Immun. 45(1), 29\u201335 (1984).","journal-title":"Infect. Immun."},{"issue":"7","key":"18826_CR15","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1086\/605563","volume":"49","author":"A Linder","year":"2009","unstructured":"Linder, A., Christensson, B., Herwald, H., Bj\u00f6rck, L. & Akesson, P. Heparin-binding protein: An early marker of circulatory failure in sepsis. Clin. Infect. Dis. 49(7), 1044\u20131050 (2009).","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"18826_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00011-011-0422-6","volume":"61","author":"MS Chew","year":"2012","unstructured":"Chew, M. S. et al. Increased plasma levels of heparin-binding protein in patients with shock: A prospective, cohort study. Inflamm. Res. 61(4), 375\u2013379 (2012).","journal-title":"Inflamm. Res."},{"issue":"2","key":"18826_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1272\/jnms.JNMS.2019_86-204","volume":"86","author":"H Wakakuri","year":"2019","unstructured":"Wakakuri, H., Hyodo, H., Ohara, T. & Yasutake, M. Serum hepcidin-25 levels reflect the presence of bacteremia in patients with systemic inflammatory response syndrome. J. Nippon Med. Sch. 86(2), 91\u201397 (2019).","journal-title":"J. Nippon Med. Sch."},{"issue":"1","key":"18826_CR18","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1186\/cc9408","volume":"15","author":"LT van Eijk","year":"2011","unstructured":"van Eijk, L. T. et al. Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: An observational study. Crit. Care 15(1), R9 (2011).","journal-title":"Crit. Care"},{"issue":"2\u20133","key":"18826_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","volume":"480","author":"A Krause","year":"2000","unstructured":"Krause, A. et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480(2\u20133), 147\u2013150 (2000).","journal-title":"FEBS Lett."},{"issue":"1","key":"18826_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpeds.2012.06.010","volume":"162","author":"TW Wu","year":"2013","unstructured":"Wu, T. W. et al. The utility of serum hepcidin as a biomarker for late-onset neonatal sepsis. J. Pediatr. 162(1), 67\u201371 (2013).","journal-title":"J. Pediatr."},{"key":"18826_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1824-7288-39-25","volume":"39","author":"L Kossiva","year":"2013","unstructured":"Kossiva, L., Soldatou, A., Gourgiotis, D. I., Stamati, L. & Tsentidis, C. Serum hepcidin: Indication of its role as an \u201cacute phase\u201d marker in febrile children. Ital. J. Pediatr. 39, 25 (2013).","journal-title":"Ital. J. Pediatr."},{"key":"18826_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3389\/fphar.2019.00615","volume":"10","author":"Y Scindia","year":"2019","unstructured":"Scindia, Y. et al. Protective role of hepcidin in polymicrobial sepsis and acute kidney injury. Front. Pharmacol. 10, 615 (2019).","journal-title":"Front. Pharmacol."},{"issue":"6","key":"18826_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1159\/000508561","volume":"12","author":"J Olinder","year":"2020","unstructured":"Olinder, J., Ehinger, D., Liljenborg, E., Herwald, H. & Ryd\u00e9n, C. Plasma levels of hepcidin and reticulocyte haemoglobin during septic shock. J. Innate Immun. 12(6), 448\u2013460 (2020).","journal-title":"J. Innate Immun."},{"issue":"11","key":"18826_CR24","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1074\/jbc.M008922200","volume":"276","author":"CH Park","year":"2001","unstructured":"Park, C. H., Valore, E. V., Waring, A. J. & Ganz, T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 276(11), 7806\u20137810 (2001).","journal-title":"J Biol Chem."},{"issue":"4","key":"18826_CR25","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","volume":"93","author":"T Ganz","year":"2013","unstructured":"Ganz, T. Systemic iron homeostasis. Physiol. Rev. 93(4), 1721\u20131741 (2013).","journal-title":"Physiol. Rev."},{"issue":"7","key":"18826_CR26","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","volume":"101","author":"E Nemeth","year":"2003","unstructured":"Nemeth, E. et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101(7), 2461\u20132463 (2003).","journal-title":"Blood"},{"issue":"9","key":"18826_CR27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI200420945","volume":"113","author":"E Nemeth","year":"2004","unstructured":"Nemeth, E. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113(9), 1271\u20131276 (2004).","journal-title":"J. Clin. Invest."},{"issue":"5","key":"18826_CR28","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1182\/blood-2005-03-1159","volume":"106","author":"E Kemna","year":"2005","unstructured":"Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H. & Swinkels, D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106(5), 1864\u20131866 (2005).","journal-title":"Blood"},{"issue":"10","key":"18826_CR29","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00134-005-2763-5","volume":"31","author":"RP Moreno","year":"2005","unstructured":"Moreno, R. P. et al. SAPS 3\u2014from evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 31(10), 1345\u201355 (2005).","journal-title":"Intensive Care Med."},{"issue":"3","key":"18826_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.vascn.2009.02.004","volume":"59","author":"H Li","year":"2009","unstructured":"Li, H. et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC\u2013MS\/MS. J. Pharmacol. Toxicol. Methods 59(3), 171\u2013180 (2009).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"5","key":"18826_CR31","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1182\/blood.V99.5.1785","volume":"99","author":"H Tapper","year":"2002","unstructured":"Tapper, H., Karlsson, A., Morgelin, M., Flodgaard, H. & Herwald, H. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood 99(5), 1785\u20131793 (2002).","journal-title":"Blood"},{"issue":"25","key":"18826_CR32","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1182\/blood-2011-02-337907","volume":"117","author":"TE Galesloot","year":"2011","unstructured":"Galesloot, T. E. et al. Serum hepcidin: Reference ranges and biochemical correlates in the general population. Blood 117(25), e218\u2013e225 (2011).","journal-title":"Blood"},{"issue":"7\u20138","key":"18826_CR33","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cca.2011.12.015","volume":"413","author":"O Itkonen","year":"2012","unstructured":"Itkonen, O., Parkkinen, J., Stenman, U. H. & Hamalainen, E. Preanalytical factors and reference intervals for serum hepcidin LC\u2013MS\/MS method. Clin. Chim. Acta 413(7\u20138), 696\u2013701 (2012).","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"18826_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/00365513.2012.735694","volume":"73","author":"M Schoorl","year":"2013","unstructured":"Schoorl, M., Snijders, D., Schoorl, M., Boersma, W. G. & Bartels, P. C. Transient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community-acquired pneumonia. Scand. J. Clin. Lab. Invest. 73(1), 54\u201360 (2013).","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"11","key":"18826_CR35","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1097\/CCM.0000000000001265","volume":"43","author":"A Linder","year":"2015","unstructured":"Linder, A. et al. Heparin-binding protein measurement improves the prediction of severe infection with organ dysfunction in the emergency department. Crit. Care Med. 43(11), 2378\u20132386 (2015).","journal-title":"Crit. Care Med."},{"issue":"2","key":"18826_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger, R. P. et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 41(2), 580\u2013637 (2013).","journal-title":"Crit. Care Med."},{"issue":"1","key":"18826_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","volume":"24","author":"C Pierrakos","year":"2020","unstructured":"Pierrakos, C., Velissaris, D., Bisdorff, M., Marshall, J. C. & Vincent, J. L. Biomarkers of sepsis: Time for a reappraisal. Crit. Care 24(1), 287 (2020).","journal-title":"Crit. Care"},{"issue":"4","key":"18826_CR38","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/bja\/aex234","volume":"119","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari, M., Harrison, D. A., Rubenfeld, G. D. & Rowan, K. Epidemiology of sepsis and septic shock in critical care units: Comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br. J. Anaesth. 119(4), 626\u2013636 (2017).","journal-title":"Br. J. Anaesth."},{"issue":"5","key":"18826_CR39","doi-asserted-by":"publisher","first-page":"R212","DOI":"10.1186\/cc13026","volume":"17","author":"A Garland","year":"2013","unstructured":"Garland, A., Olafson, K., Ramsey, C. D., Yogendran, M. & Fransoo, R. Epidemiology of critically ill patients in intensive care units: A population-based observational study. Crit. Care 17(5), R212 (2013).","journal-title":"Crit. Care"},{"issue":"5","key":"18826_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/cc2862","volume":"8","author":"M Darveau","year":"2004","unstructured":"Darveau, M., Denault, A. Y., Blais, N. & Notebaert, E. Bench-to-bedside review: Iron metabolism in critically ill patients. Crit Care. 8(5), 356\u2013362 (2004).","journal-title":"Crit Care."},{"issue":"2","key":"18826_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/cc9992","volume":"15","author":"N Heming","year":"2011","unstructured":"Heming, N., Montravers, P. & Lasocki, S. Iron deficiency in critically ill patients: Highlighting the role of hepcidin. Crit. Care 15(2), 210 (2011).","journal-title":"Crit. Care"},{"issue":"3","key":"18826_CR42","first-page":"517","volume":"48","author":"O Ye\u015filba\u015f","year":"2018","unstructured":"Ye\u015filba\u015f, O. et al. Role of hepcidin in the diagnosis of sepsis and septic shock in children. Turk. J. Med. Sci. 48(3), 517\u2013524 (2018).","journal-title":"Turk. J. Med. Sci."},{"issue":"4","key":"18826_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pedneo.2018.09.001","volume":"60","author":"JH Yan","year":"2019","unstructured":"Yan, J. H., Cai, X. Y. & Huang, Y. H. The clinical value of plasma hepcidin levels in predicting bacterial infections in febrile children. Pediatr. Neonatol. 60(4), 377\u2013381 (2019).","journal-title":"Pediatr. Neonatol."},{"issue":"6","key":"18826_CR44","doi-asserted-by":"publisher","first-page":"e567","DOI":"10.1097\/CCM.0000000000003089","volume":"46","author":"JR Cherry-Bukowiec","year":"2018","unstructured":"Cherry-Bukowiec, J. R., Engoren, M., Wiktor, A., Raghavendran, K. & Napolitano, L. M. Hepcidin and anemia in surgical critical care: A prospective cohort study. Crit. Care Med. 46(6), e567\u2013e574 (2018).","journal-title":"Crit. Care Med."},{"issue":"3","key":"18826_CR45","doi-asserted-by":"publisher","first-page":"e0152035","DOI":"10.1371\/journal.pone.0152035","volume":"11","author":"J Tyd\u00e9n","year":"2016","unstructured":"Tyd\u00e9n, J., Herwald, H., Sj\u00f6berg, F. & Johansson, J. Increased plasma levels of heparin-binding protein on admission to intensive care are associated with respiratory and circulatory failure. PLoS ONE 11(3), e0152035 (2016).","journal-title":"PLoS ONE"},{"issue":"1","key":"18826_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40635-020-00338-8","volume":"8","author":"J Tverring","year":"2020","unstructured":"Tverring, J. et al. Repeated measures of heparin-binding protein (HBP) and procalcitonin during septic shock: Biomarker kinetics and association with cardiovascular organ dysfunction. Intensive Care Med. Exp. 8(1), 51 (2020).","journal-title":"Intensive Care Med. Exp."},{"issue":"1","key":"18826_CR47","doi-asserted-by":"publisher","first-page":"15350","DOI":"10.1038\/s41598-020-72003-9","volume":"10","author":"M Bergquist","year":"2020","unstructured":"Bergquist, M. et al. TNFR1, TNFR2, neutrophil gelatinase-associated lipocalin and heparin binding protein in identifying sepsis and predicting outcome in an intensive care cohort. Sci. Rep. 10(1), 15350 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"18826_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13613-019-0542-7","volume":"9","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y. et al. Inflammatory anemia-associated parameters are related to 28-day mortality in patients with sepsis admitted to the ICU: A preliminary observational study. Ann. Intensive Care 9(1), 67 (2019).","journal-title":"Ann. Intensive Care"},{"issue":"6","key":"18826_CR49","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/CCM.0000000000001607","volume":"44","author":"F Tacke","year":"2016","unstructured":"Tacke, F. et al. Iron parameters determine the prognosis of critically Ill patients. Crit. Care Med 44(6), 1049\u20131058 (2016).","journal-title":"Crit. Care Med"},{"issue":"11","key":"18826_CR50","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.peptides.2010.08.007","volume":"31","author":"G Maisetta","year":"2010","unstructured":"Maisetta, G. et al. Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: Effect of copper and acidic pH. Peptides 31(11), 1995\u20132002 (2010).","journal-title":"Peptides"},{"issue":"8","key":"18826_CR51","doi-asserted-by":"publisher","first-page":"e1004998","DOI":"10.1371\/journal.ppat.1004998","volume":"11","author":"K Michels","year":"2015","unstructured":"Michels, K., Nemeth, E., Ganz, T. & Mehrad, B. Hepcidin and host defense against infectious diseases. PLoS Pathog. 11(8), e1004998 (2015).","journal-title":"PLoS Pathog."},{"issue":"7","key":"18826_CR52","doi-asserted-by":"publisher","first-page":"e00253-18","DOI":"10.1128\/iai.00253-18","volume":"86","author":"D Stefanova","year":"2018","unstructured":"Stefanova, D. et al. Hepcidin protects against lethal escherichia coli sepsis in mice inoculated with isolates from septic patients. Infect. Immun. 86(7), e00253\u201318. https:\/\/doi.org\/10.1128\/iai.00253-18 (2018).","journal-title":"Infect. Immun."},{"issue":"1","key":"18826_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.chom.2014.12.001","volume":"17","author":"J Arezes","year":"2015","unstructured":"Arezes, J. et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17(1), 47\u201357 (2015).","journal-title":"Cell Host Microbe"},{"issue":"2","key":"18826_CR54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/ALN.0000000000000466","volume":"122","author":"C Zeng","year":"2015","unstructured":"Zeng, C. et al. Hepatic hepcidin protects against polymicrobial sepsis in mice by regulating host iron status. Anesthesiology 122(2), 374\u2013386 (2015).","journal-title":"Anesthesiology"},{"issue":"2","key":"18826_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ccc.2018.11.014","volume":"35","author":"LS Chawla","year":"2019","unstructured":"Chawla, L. S., Beers-Mulroy, B. & Tidmarsh, G. F. Therapeutic opportunities for hepcidin in acute care medicine. Crit. Care Clin. 35(2), 357\u2013374 (2019).","journal-title":"Crit. Care Clin."},{"key":"18826_CR56","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/978-3-030-06067-1_44","volume-title":"Annual Update in Intensive Care and Emergency Medicine 2019\/Jean-Louis Vincent","author":"E Litton","year":"2019","unstructured":"Litton, E. & Lin, J. Iron metabolism: An emerging therapeutic target in critical illness. In Annual Update in Intensive Care and Emergency Medicine 2019\/Jean-Louis Vincent (ed. Vincent, J.-Le.) 573\u201382 (Springer, Cham, 2019)."},{"issue":"1","key":"18826_CR57","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13054-018-2253-0","volume":"22","author":"S Lasocki","year":"2018","unstructured":"Lasocki, S. et al. Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: An observational prospective study on 1161 patients. Crit Care 22(1), 314 (2018).","journal-title":"Crit Care"},{"issue":"65","key":"18826_CR58","doi-asserted-by":"publisher","first-page":"109497","DOI":"10.18632\/oncotarget.22722","volume":"8","author":"X Li","year":"2017","unstructured":"Li, X. et al. Associations of plasma hepcidin with mortality risk in patients with coronary artery disease. Oncotarget 8(65), 109497\u2013109508 (2017).","journal-title":"Oncotarget"},{"issue":"1","key":"18826_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nut.2014.04.019","volume":"31","author":"M Andrews","year":"2015","unstructured":"Andrews, M., Soto, N. & Arredondo-Olgu\u00edn, M. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity. Nutrition 31(1), 51\u201357 (2015).","journal-title":"Nutrition"},{"issue":"2","key":"18826_CR60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.semnephrol.2016.02.001","volume":"36","author":"T Ganz","year":"2016","unstructured":"Ganz, T. & Nemeth, E. Iron balance and the role of hepcidin in chronic kidney disease. Semin. Nephrol. 36(2), 87\u201393 (2016).","journal-title":"Semin. Nephrol."},{"issue":"1","key":"18826_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1182\/blood-2012-12-471441","volume":"122","author":"SR Pasricha","year":"2013","unstructured":"Pasricha, S. R., Frazer, D. M., Bowden, D. K. & Anderson, G. J. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with \u03b2-thalassemia major: A longitudinal study. Blood 122(1), 124\u2013133 (2013).","journal-title":"Blood"},{"issue":"3","key":"18826_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000437132","volume":"108","author":"L Lorenz","year":"2015","unstructured":"Lorenz, L. et al. Short-term effects of blood transfusions on hepcidin in preterm infants. Neonatology 108(3), 205\u2013210 (2015).","journal-title":"Neonatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18826-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18826-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18826-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T12:18:23Z","timestamp":1662034703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18826-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18826"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18826-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Hansa Medical (Lund, Sweden) has filed patent applications on HBP as a diagnostic marker. Heiko Herwald is listed as inventor. All other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14857"}}